Inspiration from natural products in heart-healthy diets used to fight cardiovascular disease
HRI’s Dr Xuyu Liu is researching how healthy heart diets that contain ‘natural products’ can give rise to new treatments for thrombosis.
New COO for the Heart Research Institute
HRI is pleased to announce that Dr Tim Gainsford has been appointed Chief Operating Officer from Monday, 5 September 2022.
Investigating platelet hyperactivity in diabetes for preventative therapies
HRI is conducting a collaborative research project investigating the mechanisms of platelet hyperactivity in diabetes with Dr Maggie Kalev-Zylinska, University of Auckland.
Developing safer treatments for ischaemic stroke
HRI has launched an international drug discovery project investigating the development of a photo-responsive therapy for ischaemic stroke.
Distinguished Prof Annemarie Hennessy AM celebrates 20 years at HRI
Distinguished Professor Annemarie Hennessy AM is celebrating 20 years at HRI as Vascular Immunology Group Leader this year.
HRI welcomes new Scientific Director, Prof Andrew Coats AO
HRI is delighted to announce that world-leading cardiovascular expert Professor Andrew Coats AO is joining the Institute as Scientific Director.
Advancing medical treatment for diabetes patients more likely to develop atherosclerosis
HRI's Dr Ashish Misra has received a 2022 Diabetes Australia research grant for his project to identify the mechanisms linking diabetes with atherosclerosis.
Is atrial fibrillation (irregular heartbeat) a cause of dementia?
Prof Ben Freedman, HRI, spoke to Health Europa Quarterly about whether atrial fibrillation (irregular heartbeat) is a cause of dementia.
Extending the CHAANZ Congenital Heart Disease Registry to NZ
HRI is establishing the Congenital Heart Alliance of Australia and New Zealand (CHAANZ) Congenital Heart Disease Registry, a comprehensive NZ registry of demographic and clinical data from cohorts of paediatric and adult cases of CHD from sites across New Zealand.